Winter leads to an increased risk of problems related to the prostate gland in seniors. Cold weather causes urinary and ...

TORONTO - Ontario's health minister says the province will now publicly fund a new treatment for advanced-stage prostate ...

In the coming months, health ministry anticipates PLUVICTO will be available for eligible patients at most of Ontario’s ...

Dr. Niti Navanimitkul, MD, from the Urology Center at Bangkok Hospital Pattaya gave an informative presentation to the ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...

The drug, known as NXP800, works by targeting the heat shock factor 1 (HSF1) pathway, a cellular protective mechanism that is ...

A breakthrough in prostate cancer treatment has seen a drug shrink tumours in advanced disease ...

The drug, known as NXP800, works by targeting the heat shock factor 1 (HSF1) pathway, a cellular protective mechanism that is ...

Prostate cancer is the most common cancer diagnosed in men, and the second most common cancer in the world, and while the outlook can be hopeful if caught early, treatment can impact a patient’s ...

Over the coming months, it is anticipated Pluvicto will be available for eligible patients at most of Ontario’s Cancer ...

The treatment of benign prostatic hyperplasia (BPH) that causes lower urinary tract symptoms has advanced enormously since the days when it was a simple choice between no treatment with ...

Ontario has introduced PLUVICTO, a new treatment for advanced-stage prostate cancer, making it the first province in Canada ...